Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
SALVO: Single-arm trial of ipilimumab and...
Conference

SALVO: Single-arm trial of ipilimumab and nivolumab as adjuvant therapy for resected mucosal melanoma.

Authors

Kottschade LA; Pond GR; Olszanski AJ; Zakharia Y; Domingo-Musibay E; Hauke RJ; Curti BD; Schober S; Milhem MM; Block MS

Volume

40

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

June 1, 2022

Name of conference

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference place

ELECTR NETWORK

Conference start date

June 3, 2022

Conference end date

June 7, 2022

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

16

ISSN

0732-183X

Labels

Fields of Research (FoR)